Barclays’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $379K | Sell |
15,601
-20,774
| -57% | -$505K | ﹤0.01% | 3180 |
|
|
2025
Q1 | $755K | Buy |
36,375
+14,375
| +65% | +$298K | ﹤0.01% | 2603 |
|
|
2024
Q4 | $518K | Sell |
22,000
-263,108
| -92% | -$6.19M | ﹤0.01% | 3030 |
|
|
2024
Q3 | $7.3M | Buy |
285,108
+204,283
| +253% | +$5.23M | ﹤0.01% | 1236 |
|
|
2024
Q2 | $1.9M | Sell |
80,825
-60,410
| -43% | -$1.42M | ﹤0.01% | 1744 |
|
|
2024
Q1 | $4.06M | Buy |
141,235
+133,341
| +1,689% | +$3.84M | ﹤0.01% | 1490 |
|
|
2023
Q4 | $259K | Sell |
7,894
-44,226
| -85% | -$1.45M | ﹤0.01% | 3395 |
|
|
2023
Q3 | $1.45M | Buy |
52,120
+51,060
| +4,817% | +$1.42M | ﹤0.01% | 1857 |
|
|
2023
Q2 | $36K | Hold |
1,060
| – | – | ﹤0.01% | 3804 |
|
|
2023
Q1 | $32K | Sell |
1,060
-1,389
| -57% | -$41.9K | ﹤0.01% | 3889 |
|
|
2022
Q4 | $69K | Sell |
2,449
-8,896
| -78% | -$251K | ﹤0.01% | 3653 |
|
|
2022
Q3 | $373K | Sell |
11,345
-47,060
| -81% | -$1.55M | ﹤0.01% | 2748 |
|
|
2022
Q2 | $1.84M | Buy |
58,405
+8,800
| +18% | +$277K | ﹤0.01% | 1636 |
|
|
2022
Q1 | $2.28M | Buy |
49,605
+2,454
| +5% | +$113K | ﹤0.01% | 1685 |
|
|
2021
Q4 | $2.89M | Buy |
47,151
+37,410
| +384% | +$2.29M | ﹤0.01% | 1584 |
|
|
2021
Q3 | $728K | Buy |
9,741
+210
| +2% | +$15.7K | ﹤0.01% | 2421 |
|
|
2021
Q2 | $882K | Sell |
9,531
-560
| -6% | -$51.8K | ﹤0.01% | 2181 |
|
|
2021
Q1 | $896K | Buy |
10,091
+1,560
| +18% | +$139K | ﹤0.01% | 2358 |
|
|
2020
Q4 | $796K | Buy |
+8,531
| New | +$796K | ﹤0.01% | 2095 |
|